Abstract
Introduction and hypothesis
Our aim was to characterize pelvic floor symptoms in postmenopausal women who had undergone osteoporosis evaluation and examine their association with bone mineral density (BMD).
Methods
Pelvic floor symptom questionnaires were mailed to 4,026 women. Multivariate logistic regression models controlling for age, race, body mass index (BMI), and chronic obstructive pulmonary disease (COPD) were performed comparing symptoms in women with osteoporosis (T score ≤ −2.5) and osteopenia (T score > −2.5 to < −1) at any site to women with normal BMD (T score: ≥ −1, referent).
Results
There were 1,774/4,026 (44 %) questionnaires returned; 1,655 were included in the analysis (362 osteoporosis, 870 osteopenia, 423 normal BMD). Overall prevalence of any urinary incontinence (UI) was 1,226/1,640 (75 %), with UI ≥2–3 times/week in 699/1,197 (58 %), fecal incontinence over the past month in 247/1,549 (16 %), and prolapse in 162/1,582 (10 %). Multivariate analyses revealed that women with osteopenia had increased risk of incontinence of solid stool [adjusted odds ratio (aOR) 1.7, 95 % confidence interval (CI) 1.1–2.4). Risk of UI ≥2–3 times/week was not increased in women with osteoporosis (aOR 0.9, CI 0.6–1.3) and was lower in women with osteopenia (aOR 0.7, CI 0.5–0.9). In women with osteoporosis, the odds of moderate- to large-volume urine loss versus small/none was higher for those in the lower T-score quartile (lower BMD; aOR 1.43, CI 1.1–1.9).
Conclusions
In women undergoing osteoporosis evaluation, those with osteopenia were at increased risk of fecal incontinence but not UI compared with normal women. Osteoporotic women with the lowest T scores had higher risk of moderate- to large-volume UI. It is unclear whether there is a pathophysiologic link between BMD loss and development of pelvic floor symptoms.
Similar content being viewed by others
References
Goode PS, Burgio KL, Richter HE, Markland AD (2010) Incontinence in older women. JAMA 303:2172–2181
Sexton CC, Coyne KS, Thompson C, Bavendam T, Chen C-I, Markland A (2001) Prevalence and effect on health-related quality of life of overactive bladder in older Americans: Results from the Epidemiology of lower urinary tract symptoms study. J Am Geriatr Soc 59:1465–1470
Markland AD, Goode PS, Burgio KL, Redden DT, Richter HE, Sawyer P et al (2010) Incidence and risk factors for fecal incontinence in black and white older adults: a population-based study. J Am Geriatr Soc 58:1341–1346
Markland AD, Richter HE, Fwu C-W, Eggers P, Kusek JW (2011) Prevalence and trends of urinary incontinence in adults in the United States 2001 to 2008. J Urol 186:589–593
Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S et al (2008) Prevalence of symptomatic pelvic floor disorders in US women. JAMA 300:1311–1316
Jonsson Funk M, Levin PJ, Wu JM (2012) Trends in the surgical management of stress urinary incontinence. Obstet Gynecol 119:845–851
Bradley SL, Weidner AC, Siddiqui NY, Gandhi MP, Wu JM (2011) Shifts in national rates of inpatient prolapse surgery emphasize current coding inadequacies. Female Pelvic Med Reconstr Surg 17:204–208
Smith AR, Hosker GL, Warrell DW (1989) The role of partial denervation of the pelvic floor in the aetiology of genitourinary prolapse and stress incontinence of urine: a neurophysiological study. Br J Obstet Gynaecol 96:24–28
Delancey JOL, Morgan DM, Fenner DE, Kearney R et al (2007) Comparison of levator ani muscle defects in women with and without pelvic organ prolapse. Obstet Gynecol 109:295–302
Liu X, Zhao PB, Damaser M, Li T (2006) Failure of elastic fiber homeostasis leads to pelvic floor disorders. Am J Pathol 168:519–528
Chen B, Yeh J (2011) Alterations in connective tissue metabolism in stress incontinence and prolapse. J Urol 186:1768–1772
Vardy MD, Lindsay R, Scotti RJ, Mikhail M et al (2003) Short term urogenital effects of raloxifene, tamoxifen and estrogen. Am J Obstet Gynecol 189:81–88
Cauley JA (2011) Defining ethnic and racial differences in osteoporosis and fragility fractures. Clin Orthop Relat Res 469:1891–1899
National Osteoporosis Foundation (2010) Clinician’s guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010. Available at: http://www.nof.org/hcp/practice/practice-and-clinical-guidelines/clinicians-guide Accessed June 2012
Correa PHS, Martin RM (2010) Bone quality and osteoporosis therapy. Arq Bras Endocrinol Metab 52:186–199
Saito M, Marumo K (2010) Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 21:195–214
Haylen BT, de Ridder D, Freeman RM, Swift SE et al (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21:5–26
Brown J, Bradley AS, Subak LL, Richter HE, Kraus SR et al (2006) The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence. Ann Intern Med 144:715–723
Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P (2004) ICIQ: a brief and robust measure for evaluation the symptoms and impact of urinary incontinence. Neurourol Urodyn 23:322–330
Kwon S, Visco AG, Fitzgerald MP et al (2005) Validity and reliability of the Modified Manchester Health Questionnaire in assessing patients with fecal incontinence. Dis Colon Rectum 48:323–334
Barber MD, Walters MD, Bump RC (2005) Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol 193:103–113
Barber MD, Neubauer NL, Klein-Olarte V (2006) Can we screen for pelvic organ prolapse without a physical examination in epidemiologic studies? Am J Obstet Gynecol 195:942–948
Lewis SJ, Heaton KW (1997) Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 32:920–924
Kanis JA, 3rd Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137–1141
Sran MM (2009) Prevalence of urinary incontinence in women with osteoporosis. J Obstet Gynaecol Can 31:434–439
Klovning A, Avery K, Sandvik H, Hunskaar S (2009) Comparison of two questionnaires for assessing the severity of urinary incontinence: the ICIQ-UI SF versus the Incontinence Severity Index. Neurourol Urodyn 28:411–415
Nilsson M, Lalos A, Lalos O (2009) The impact of female urinary incontinence and urgency on quality of life and partner relationship. Neurourol Urodyn 28:976–981
McGrother CW, Donaldson MMK, Hayword T, Matthews R, Dallosso HM et al (2006) Urinary storage symptoms and comorbidities: a prospective population cohort study in middle-aged and older women. Age Ageing 35:16–24
Speakman CTM, Hoyle CHV, Kamm MA, Swash M, Henry MM et al (1995) Abnormal internal anal sphincter fibrosis and elasticity in fecal incontinence. Dis Colon Rectum 38:407–410
Acknowledgments
We acknowledge Ligong Chen, PhD, and Alice A. Howell, RN, BSN, CCRC, for their assistance with this project.
Conflicts of interest
HER-Astellas Consultant, Pelvalon research funding, no COI; SLM-ISCD Board and Amgen Consultant, no COI; JLG-no disclosures or COI; JMS-no disclosures or COI; PSG-Pfizer research funding, no COI; KLB-Pfizer Consultant, no COI. Funding sources wer the University of Alabama at Birmingham, Protective Life Clinical Initiatives (PLCI) Award Program; partially supported by the National Institutes of Diabetes and Digestive and Kidney Diseases, 2K24-DK068389 to HER
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Richter, H.E., Morgan, S.L., Gleason, J.L. et al. Pelvic floor symptoms and bone mineral density in women undergoing osteoporosis evaluation. Int Urogynecol J 24, 1663–1669 (2013). https://doi.org/10.1007/s00192-013-2056-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-013-2056-4